4/A//SEC Filing
Hermelin David S 4/A
Accession 0001140361-10-038763
CIK 0000057055other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:05 PM ET
Size
7.8 KB
Accession
0001140361-10-038763
Insider Transaction Report
Form 4/AAmended
KV PHARMACEUTICAL CO /DE/KVA / KVB
Hermelin David S
DirectorVice PresidentOther
Transactions
- Award
Option to Purchase
2009-01-13+15,000→ 15,000 totalExercise: $2.95Exp: 2019-01-13→ Class A Common Stock (15,000 underlying) - Award
Option to Purchase
2010-09-07+10,000→ 10,000 totalExercise: $1.62Exp: 2020-09-07→ Class A Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The option vested in four equal quarterly installments beginning on March 31, 2009.
- [F2]The option vests in five equal annual installments beginning on September 7, 2011.
Documents
Issuer
KV PHARMACEUTICAL CO /DE/
CIK 0000057055
Entity typeother
Related Parties
1- filerCIK 0001296276
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 4:05 PM ET
- Size
- 7.8 KB